The BNT162 mRNA vaccine candidate is currently in preclinical testing with the start of clinical trials expected in April 2020.
Chanjo iliyoteuliwa inayotegeme mRNA, BN162, kwa sasa inapimwa kwa wanyama na vipimo hivyo vya kliniki vinatarajiwa kuanza mwezi wa Aprili 2020.